← Eichor
Condition: Urinary Frequency Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Urinary Frequency

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Micturition Desire-Relaxation Training Device for Lower Urinary Tract Dysfunction in Children
NA · 1 location(s) · Shanghai Children's Medical Center · NCT07000656Randomized Controlled Trial Comparing Low Dose Tadalafil Versus Solifenacin For Management of Overactive Bladder in Wome
Phase 4 · 14 location(s) · Mansoura University · NCT07416968Platelet-Rich Plasma Versus Botulinum Toxin for Refractory Overactive Bladder: A Randomized Trial
NA · 1 location(s) · Benha University · NCT07184307Safety and Efficacy of Aloe Vera in the Management of the Symptoms of Interstitial Cystitis
EARLY_Phase 1 · 1 location(s) · Wake Forest University Health Sciences · NCT04734106Percutaneous Nerve Evaluation Trial Time
NA · 1 location(s) · University of Chicago · NCT06226220Safety and Performance of UCon Patch Electrode
NA · 3 location(s) · InnoCon Medical · NCT06754189PMCF Study of the Axonics SNM System Model 5101 (R20) for the Indication of OAB
NA · 5 location(s) · Axonics, Inc. · NCT06789406Aquarius Pilot Study to Evaluate the New Axonics Trial System
NA · 2 location(s) · Axonics, Inc. · NCT07335484Validity and Reliability of the PRAFAB
Phase N/A · 1 location(s) · Afyonkarahisar Health Sciences University · NCT07339657UCon Treatment of Overactive Bladder (OAB) in Males
NA · 1 location(s) · InnoCon Medical · NCT05874375Fluoroscopy Radiation Reduction During Sacral Neuromodulation Lead Placement
NA · 1 location(s) · Loma Linda University · NCT04527445Changes in the Impact of Genitourinary Syndrome of Menopause With a Novel Nonhormonal Vulvovaginal Gel Assessed by PROMs
NA · 1 location(s) · Mucosa Innovations, S.L. · NCT06962345APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
NA · 10 location(s) · Medstar Health Research Institute · NCT06797245Low-Energy Shock Wave Therapy for Overactive Bladder in Women With Metabolic Syndrome
NA · 1 location(s) · KMUHIRB-F(I)-20230051 · NCT07563764Genetic Study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)
Phase N/A · 1 location(s) · Boston Children's Hospital · NCT00499317Investigation of PEMF Therapy for Female Patients With IC/BPS
NA · 1 location(s) · Wake Forest University Health Sciences · NCT05149573Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syn
Phase 2 · 5 location(s) · Vaneltix Pharma, Inc. · NCT06394830BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder
NA · 1 location(s) · Corewell Health East · NCT04873037Safety and Performance of UCon Bar Electrode for the Treatment of Overactive Bladder (OAB) and Bowel Dysfunction (BD)
NA · 3 location(s) · InnoCon Medical · NCT06091566Post-procedural Pain Associated With 5 Versus 20 Intravesical Injections of Onabotulinumtoxin A
Phase 4 · 2 location(s) · University of South Florida · NCT04305743Identifying Genetic Causes of IC/BPS
Phase N/A · 1 location(s) · Boston Children's Hospital · NCT00389142Sacral Neuromodulation for Male Overactive Bladder (MOAB)
NA · 21 location(s) · Axonics, Inc. · NCT06511141
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.